vimarsana.com

Page 70 - ப்ரேசெனிுச் மருத்துவ பராமரிப்பு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

End Stage Renal Disease Market Deep Research Study Analysis Report with Forecast by 2030

Fresenius building renal genomic registry to inform precision care for kidney disease

Fresenius building renal genomic registry to inform precision care for kidney disease Neil Versel, Genomeweb Getty Images/iStockphoto The Frenova research division of global nephrology care firm Fresenius Medical Care this month began enrolling patients in what the company expects to be the world s largest renal genomic registry. Fresenius hopes that the registry will grow to include biosamples from 100,000 to 200,000 patients over the next five to six years. We have a goal just in this year of consenting and doing our initial sequencing on up to 20,000 patients, said Fresenius Medical Care global Chief Medical Officer Franklin Maddux. Fresenius Medical Care focuses mostly but not exclusively on kidney care. The publicly traded firm includes a products division, a services division, and an arm for value-based care risk contracting.

Apheresis Market: Industry Trends, Size, Key Players, COVID-19 Impact Analysis, Opportunity and Forecast till 2023

Apheresis Market: Industry Trends, Size, Key Players, COVID-19 Impact Analysis, Opportunity and Forecast till 2023
sandiegosun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sandiegosun.com Daily Mail and Mail on Sunday newspapers.

RenalSense Announces Distribution Agreement in Israel with Medtechnica

RenalSense Announces Distribution Agreement in Israel with Medtechnica USA - English Share this article JERUSALEM, Jan. 25, 2021 /PRNewswire/  RenalSense, a leading company in real-time renal diagnostics, today announced a distribution agreement with Medtechnica, Israel s largest distributor of medical equipment and health services. Medtechnica will market RenalSense s Clarity RMS™ critical care monitoring system to hospitals throughout Israel. Clarity RMS has been clinically proven to facilitate early detection of changes in renal function and Acute Kidney Injury (AKI) risk, and is installed in a number of intensive care units (ICU) in leading medical centers around the world. The system continuously measures urine flow, automatically transmitting real-time data and notifications of fluctuations to enable rapid intervention, monitoring of treatment efficacy and fluid management.

Dural Arteriovenous Fistulas Treatment Market 2021 - Investment Strategy, Outlook and Key Development till 2023

Dural Arteriovenous Fistulas Treatment Market 2021 - Investment Strategy, Outlook and Key Development till 2023
texasguardian.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from texasguardian.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.